Riskpilot← Back to searchSign inGet full accessNordic Range AB
ABActiveOrg 5593425928Industrivägen 19Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20211 employees
Revenue 2024
SEK 4M
+485% vs 2023
EBITDA margin
0.7%
+105% vs 2023
Equity ratio
2.4%
Financial strength
Net profit 2024
SEK 26K
+104% vs 2023
| Revenue | SEK 4M | +485% |
| EBITDA | SEK 30K | +105% |
| Net profit | SEK 26K | +104% |
| Total assets | SEK 4,9M | +299% |
| Equity | SEK 118K | +28% |
| Employees | 1 | — |
Legal name
Nordic Range AB
Org number
5593425928
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25 oktober 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska ha till föremål för sin verksamhet att bedriva partihandel med läkemedel och därmed förenlig verksamhet.
Address
Industrivägen 19
Email
david.bonnier@nordicrange.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 685 | 4 007 |
| Staff expenses | −3 | −10 | −564 |
| EBITDA | −362 | −640 | 30 |
| Depreciation & amort. | — | — | — |
| EBIT | −362 | −640 | 30 |
| Net financials | — | −16 | −4 |
| Profit before tax | −362 | −657 | 26 |
| Tax | — | — | — |
| Net profit | −362 | −657 | 26 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 51 | 1 241 | 4 948 |
| Equity | 48 | 92 | 118 |
| Long-term debt | — | — | — |
| Short-term debt | 3 | 1 149 | 4 830 |
| Total debt | 3 | 1 149 | 4 830 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20222024
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20222024
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
20222024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20222024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20222024
Debt / equity
40.99×
This company
0.62×
Market median
-6511% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-25 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JF Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDx Pharma AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORDx Pharma AB
Nordic Range AB Board members of Nordic Range AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Frederick Schnell | Chief Executive Officer | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Emma Maria Birgitta Wik | Deputy Board Member | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Emelie Sofia Bergh | Deputy Board Member | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Rolf Stefan Janse | Deputy Board Member | 0 companies |
| P Alexandra M De Wever Treschow | Deputy Board Member | 0 companies |
| Carl-David Bonnier | Board of Directors | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Darlene Celeste Austria | Deputy Board Member | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |